RECURRENT ACUTE MYELOID LEUKEMIA
Clinical trials for RECURRENT ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug combo tested to keep Kids' leukemia at bay after transplant
Disease control Not yet recruitingThis early-stage study aims to find a safe dose and understand the side effects of an oral drug combination called ASTX727, given with a white blood cell booster (filgrastim), in children with high-risk acute myeloid leukemia (AML). The treatment is given as 'maintenance therapy'…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Sweet solution? Gum-Sugar wipes aim to shield sick kids from deadly infections
Prevention Not yet recruitingThis study is testing whether special dental wipes containing xylitol, a natural sugar, can prevent serious bloodstream infections in children and young adults being treated for acute myeloid leukemia (AML). Chemotherapy weakens the immune system, making patients vulnerable to in…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC